Luís Pereira de Almeida is principal investigator of the Center for Neuroscience and Cell Biology (CNC), and tenured associate professor at the Faculty of Pharmacy of the University of Coimbra. The research of his group involves gene therapy approaches for neurodegenerative disorders with a focus on Machado-Joseph disease/spinocerebellar ataxia type 3, including disease modifying and gene silencing approaches, autophagy activation and proteolysis inhibition.
Share This Speaker
